Heartburn has been in the news a lot lately — and we’re not referring to the type you might experience while watching a talking head or pundit on CNN, Fox News, or MSNBC. Rather, we’re referencing recent reports that drugs commonly used to alleviate symptoms associated with heartburn, gastroesophageal reflux disease (GERD), acid reflux, and stomach and small intestine ulcers, may raise the risk of numerous fatal health conditions. Among these risks are cardiovascular disease, chronic kidney disease, and upper gastrointestinal cancer. One such study — Estimates of mortality associated with proton pump inhibitors among US veterans — was published in May 2019 in the British Medical Journal. In that peer-reviewed study, researchers from the Department of Veterans Affairs-Saint Louis, Saint Louis University, and Washington University School of Medicine in Saint Louis concluded taking proton pump inhibitors (PPIs) is associated with